Cheri Deal

8.9k total citations · 1 hit paper
113 papers, 5.4k citations indexed

About

Cheri Deal is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Cheri Deal has authored 113 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Endocrinology, Diabetes and Metabolism, 50 papers in Genetics and 43 papers in Molecular Biology. Recurrent topics in Cheri Deal's work include Growth Hormone and Insulin-like Growth Factors (42 papers), Genetic Syndromes and Imprinting (24 papers) and Sexual Differentiation and Disorders (14 papers). Cheri Deal is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (42 papers), Genetic Syndromes and Imprinting (24 papers) and Sexual Differentiation and Disorders (14 papers). Cheri Deal collaborates with scholars based in Canada, United States and United Kingdom. Cheri Deal's co-authors include Jean Paquette, Guy Van Vliet, Constantin Polychronakos, Cynthia G. Goodyer, Nick Giannoukakis, Céline Huot, Judith L. Ross, Françoise Wilkin, Alan D. Rogol and Jan M. Wit and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Cheri Deal

109 papers receiving 5.2k citations

Hit Papers

Consensus Statement on the Diagnosis and Treatment of Chi... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheri Deal Canada 37 2.4k 2.2k 1.9k 1.3k 697 113 5.4k
Steven D. Chernausek United States 42 3.2k 1.3× 2.5k 1.2× 1.7k 0.9× 1.3k 1.0× 656 0.9× 116 6.1k
Ze’ev Hochberg Israel 49 3.1k 1.3× 2.2k 1.0× 1.6k 0.8× 1.1k 0.8× 605 0.9× 242 7.4k
Reiko Horikawa Japan 34 1.8k 0.7× 2.1k 0.9× 1.5k 0.8× 1.2k 0.9× 579 0.8× 225 6.4k
Roland Pfäffle Germany 29 2.2k 0.9× 1.2k 0.6× 1.3k 0.6× 807 0.6× 458 0.7× 131 4.1k
Stenvert L. S. Drop Netherlands 43 2.6k 1.1× 3.9k 1.8× 2.6k 1.4× 845 0.6× 1.0k 1.5× 168 6.4k
Stefano Cianfarani Italy 37 2.0k 0.8× 1.3k 0.6× 868 0.4× 1.6k 1.2× 558 0.8× 185 4.8k
Philippe Touraine France 44 2.3k 0.9× 2.4k 1.1× 1.6k 0.8× 516 0.4× 534 0.8× 195 6.1k
Tomonobu Hasegawa Japan 41 2.0k 0.8× 3.2k 1.5× 2.1k 1.1× 631 0.5× 756 1.1× 360 6.1k
Fernando Cassorla Chile 38 2.7k 1.1× 1.5k 0.7× 946 0.5× 1.1k 0.8× 408 0.6× 152 4.9k
Guy Van Vliet Canada 46 3.7k 1.5× 2.7k 1.2× 1.8k 0.9× 1.3k 1.0× 769 1.1× 185 6.6k

Countries citing papers authored by Cheri Deal

Since Specialization
Citations

This map shows the geographic impact of Cheri Deal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheri Deal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheri Deal more than expected).

Fields of papers citing papers by Cheri Deal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheri Deal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheri Deal. The network helps show where Cheri Deal may publish in the future.

Co-authorship network of co-authors of Cheri Deal

This figure shows the co-authorship network connecting the top 25 collaborators of Cheri Deal. A scholar is included among the top collaborators of Cheri Deal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheri Deal. Cheri Deal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nayak, Satyaprakash, Michael P. Wajnrajch, Joan Korth‐Bradley, et al.. (2025). IGF-1 Assessment During Weekly Somatrogon Treatment in Pediatric Patients With GH Deficiency. Journal of the Endocrine Society. 9(2). bvaf001–bvaf001. 2 indexed citations
3.
Lepage, Jean‐François, et al.. (2014). Empathy, autistic traits, and motor resonance in adults with Turner syndrome. Social Neuroscience. 9(6). 1–9. 14 indexed citations
4.
Blum, Werner, Judith L. Ross, Alan G. Zimmermann, et al.. (2013). GH Treatment to Final Height Produces Similar Height Gains in Patients With SHOX Deficiency and Turner Syndrome: Results of a Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism. 98(8). E1383–E1392. 66 indexed citations
5.
Samuels, Mark E., Nicole Gallo‐Payet, Lysanne Patry, et al.. (2013). Bioinactive ACTH Causing Glucocorticoid Deficiency. The Journal of Clinical Endocrinology & Metabolism. 98(2). 736–742. 37 indexed citations
7.
Lepage, Jean‐François, Cédric Clouchoux, Maryse Lassonde, et al.. (2011). Abnormal motor cortex excitability is associated with reduced cortical thickness in X monosomy. Human Brain Mapping. 34(4). 936–944. 12 indexed citations
8.
Paquette, Jean, et al.. (2010). Risk of autoimmune diabetes in APECED: association with short alleles of the 5′insulin VNTR. Genes and Immunity. 11(7). 590–597. 12 indexed citations
10.
Deal, Cheri, et al.. (2006). Normal minipuberty of infancy in boys with Prader-Willi syndrome. The Journal of Pediatrics. 149(6). 874–876. 33 indexed citations
11.
Anglin, Greg, et al.. (2006). Genomic Imprinting in Turner Syndrome: Effects on Response to Growth Hormone and on Risk of Sensorineural Hearing Loss. The Journal of Clinical Endocrinology & Metabolism. 91(8). 3002–3010. 47 indexed citations
12.
Perry, Rebecca, et al.. (2005). Primary Adrenal Insufficiency in Children: Twenty Years Experience at the Sainte-Justine Hospital, Montreal. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3243–3250. 122 indexed citations
13.
Deal, Cheri, et al.. (2004). Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. The Journal of Pediatrics. 144(6). 747–752. 61 indexed citations
14.
Irwin, Juan C., Bi‐Hua Cheng, Robert L. Martin, et al.. (2000). Human Placental Trophoblasts Secrete a Disintegrin Metalloproteinase Very Similar to the Insulin-Like Growth Factor Binding Protein-3 Protease in Human Pregnancy Serum1. Endocrinology. 141(2). 666–674. 20 indexed citations
15.
Paquette, Jean, Nick Giannoukakis, Constantin Polychronakos, Petros Vafiadis, & Cheri Deal. (1998). The INS 5′ Variable Number of Tandem Repeats Is Associated with IGF2 Expression in Humans. Journal of Biological Chemistry. 273(23). 14158–14164. 112 indexed citations
16.
Oligny, Luc L., et al.. (1997). Childhood adrenocortical tumors: Case series and reevaluation of prognosis—A 24-year experience. Journal of Pediatric Surgery. 32(6). 911–915. 47 indexed citations
17.
Taback, Shayne, R. Collu, Cheri Deal, et al.. (1996). Does growth-hormone supplementation affect adult height in Turner's syndrome?. The Lancet. 348(9019). 25–27. 54 indexed citations
18.
Polychronakos, Constantin, Nick Giannoukakis, & Cheri Deal. (1995). Imprinting of IGF2, insulin‐dependent diabetes, immune function, and apoptosis: A hypothesis. Developmental Genetics. 17(3). 253–262. 27 indexed citations
19.
Deal, Cheri. (1995). Parental genomic imprinting. Current Opinion in Pediatrics. 7(4). 445–458. 10 indexed citations
20.
Deal, Cheri, et al.. (1995). The growth hormone (GH)-independent growth of the obese Zucker rat is not due to increased levels of GH receptor messenger RNA in the liver. Molecular and Cellular Endocrinology. 113(2). 215–223. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026